EONIQ EVOLVE+ BLUE | Methylene Blue + Ergothioneine Cellular & Mitochondrial Support

EONIQ EVOLVE+ BLUE

Methylene Blue + Ergothioneine | Cellular Energy • Clarity • Antioxidant Support

EVOLVE+ BLUE is EONIQ’s premium liquid cellular-support formula, pairing two distinctive compounds—USP Methylene Blue and Ergothioneine—in a convenient once-daily liquid.

Designed around mitochondrial function, cellular energy, cognitive performance, and antioxidant defense, EVOLVE+ BLUE brings together 10 mg Methylene Blue and 20 mg Ergothioneine per 1 mL serving in a naturally flavored Blue Raspberry formula.

Why EVOLVE+ BLUE?

Mitochondrial Support* — Methylene Blue has been extensively studied in connection with mitochondrial electron transport and cellular bioenergetics.

Cellular Energy* — Formulated to support efficient cellular energy production and everyday vitality.

Cognitive Performance* — Supports mental energy, focus, and clarity.*

Antioxidant Defense* — Ergothioneine is a naturally occurring sulfur-containing amino-acid derivative studied for its antioxidant and cellular-protective properties.

Healthy Aging Support* — A two-ingredient active formula designed around long-term cellular and mitochondrial health.

Supplement Facts

Serving Size: 1 mL (1 Dropper)

Servings Per Container: 30

Methylene Blue (USP) — 10 mg

Ergothioneine — 20 mg

† Daily Value (DV) not established.

Other Ingredients: Purified Water, Vegetable Glycerin, Natural Blue Raspberry Flavor, Citric Acid.

Size: 30 mL (1 fl oz)

Flavor: Blue Raspberry

Form: Liquid Dietary Supplement

EONIQ — Science for a Longer Tomorrow™

EVOLVE+ BLUE was developed for people looking beyond conventional daily supplementation toward cellular energy, mitochondrial performance, antioxidant defense, and longevity-focused nutrition.

Suggested Use: Take 1 mL daily or as directed by a qualified healthcare professional.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.